Abstract
Microorganisms of millions species exist in every corner of the Earth, and form a dynamic genetic reservoir that are not clearly revealed and categorized due to barrier in current cultivation technology. Their applications in biomedical and environmental aspects are more than satisfactory. However, the situation has drastically changed during the turn of the century because of the rapid development of phylogenetic studies based on rRNA sequencing independent of standard laboratory cultivation. More recently, high throughput sequencing technology which enables direct sequencing of community DNA for metagenomic analyses are making a direct impact on our understanding of microbial diversity, ecology, and secondary metabolism. In this review, we highlight some recent progress and innovation on metagenomic research with an emphasis on natural product drug discovery. The rapid path of accumulating decoded metagenomics would be an efficient guide on direct access to the genomes of numerous non-culturable microorganisms for their genomic diversity and associated chemical prosperity for potential medicinal applications.
Keywords: Metagenomics, microbial diversity, drug discovery, bacterial artificial chromosome
Current Topics in Medicinal Chemistry
Title: Exploring and Exploiting Microbial Diversity through Metagenomics for Natural Product Drug Discovery
Volume: 9 Issue: 16
Author(s): Xiang Li, Jun Guo, Shikun Dai, Yongchang Ouyang, Houbo Wu, Wei Sun and Guanghua Wang
Affiliation:
Keywords: Metagenomics, microbial diversity, drug discovery, bacterial artificial chromosome
Abstract: Microorganisms of millions species exist in every corner of the Earth, and form a dynamic genetic reservoir that are not clearly revealed and categorized due to barrier in current cultivation technology. Their applications in biomedical and environmental aspects are more than satisfactory. However, the situation has drastically changed during the turn of the century because of the rapid development of phylogenetic studies based on rRNA sequencing independent of standard laboratory cultivation. More recently, high throughput sequencing technology which enables direct sequencing of community DNA for metagenomic analyses are making a direct impact on our understanding of microbial diversity, ecology, and secondary metabolism. In this review, we highlight some recent progress and innovation on metagenomic research with an emphasis on natural product drug discovery. The rapid path of accumulating decoded metagenomics would be an efficient guide on direct access to the genomes of numerous non-culturable microorganisms for their genomic diversity and associated chemical prosperity for potential medicinal applications.
Export Options
About this article
Cite this article as:
Li Xiang, Guo Jun, Dai Shikun, Ouyang Yongchang, Wu Houbo, Sun Wei and Wang Guanghua, Exploring and Exploiting Microbial Diversity through Metagenomics for Natural Product Drug Discovery, Current Topics in Medicinal Chemistry 2009; 9(16) . https://dx.doi.org/10.2174/156802609789909849
DOI https://dx.doi.org/10.2174/156802609789909849 |
Print ISSN 1568-0266 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4294 |

- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility Of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
- Forthcoming Thematic Issues
Related Articles
-
Osteoprotegerin and Diabetes-Associated Pathologies
Current Molecular Medicine Erythropoietin: New Horizon in Cardiovascular Medicine
Recent Patents on Cardiovascular Drug Discovery Clopidogrel Generic Formulations in the Era of New Antiplatelets: A Systematic Review
Current Vascular Pharmacology Role of C-Reactive Protein in Acute Myocardial Infarction and Stroke: Possible Therapeutic Approaches
Current Pharmaceutical Biotechnology Achilles Tendon in Diabetes
Current Diabetes Reviews Effects of Lipid-Lowering Drugs on Adiponectin
Current Vascular Pharmacology Hypertension and Angiogenesis
Current Pharmaceutical Design Magnesium and Anaesthesia
Current Drug Targets Oxidative Stress: Meeting Multiple Targets in Pathogenesis of Diabetic Nephropathy
Current Drug Targets Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases
Current Medicinal Chemistry Dysglycemia and Abdominal Obesity
Current Vascular Pharmacology Studies on the Biotransformations and Biodistributions of Metal-Containing Drugs Using X-Ray Absorption Spectroscopy
Current Topics in Medicinal Chemistry The Role of Inflammatory Biomarkers in the Detection and Therapy of Atherosclerotic Disease
Current Vascular Pharmacology Hepatoma Derived Growth Factor is a Nuclear Targeted Mitogen
Current Drug Targets Heart Failure in East Asia
Current Cardiology Reviews Genetics and Genomics of Hepatic Acute Phase Reactants: A Mini-Review
Inflammation & Allergy - Drug Targets (Discontinued) Editorial [Inflammation and Atherosclerosis: Recent Insights and Future Perspectives]
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Protein Tyrosine Nitration: Role in Aging
Current Aging Science Neurological Complications of Anderson-Fabry Disease
Current Pharmaceutical Design HPA Axis Function During the Perinatal Period in Patients with Affective Disorders
Current Psychiatry Reviews